## **Core Concept**
The condition described is suggestive of **Osler-Weber-Rendu syndrome**, also known as **Hereditary Hemorrhagic Telangiectasia (HHT)**. This is a genetic disorder characterized by the presence of multiple arteriovenous malformations (AVMs) that can affect various organs, including the skin, mucous membranes, and viscera. The lesions typically appear as telangiectasias, which are small, dilated blood vessels near the surface of the skin or mucous membranes.

## **Why the Correct Answer is Right**
The correct answer, **Tranexamic acid** or more likely **Propranolol** or a drug like **Sirolimus**, but most specifically **Bevacizumab** (not listed but related) or actually **Lenvatinib** (a multiple kinase inhibitor) in combination with **Etoposide** or **Sirolimus** but most accurately from recent approvals and usage **Lenalidomide** and especially **Pazopanib** but the best match from given and recent usage is **Sirolimus**. However, given that **Sirolimus** (also known as rapamycin) has shown efficacy in managing the condition by reducing the severity and frequency of epistaxis and lesions, it stands out. Sirolimus works by inhibiting the mammalian target of rapamycin (mTOR), which plays a critical role in cell proliferation and survival.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option might seem plausible but lacks specificity to recent approvals for HHT.
- **Option B:** Similarly, this could be considered but does not directly align with recent treatments approved for this condition.
- **Option D:** This option does not match the recent treatment modalities for HHT.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that patients with **Hereditary Hemorrhagic Telangiectasia (HHT)** often present with recurrent epistaxis (nosebleeds), mucocutaneous telangiectasias, and AVMs in various organs. A recent and notable treatment approach involves the use of **Sirolimus**, which has shown promise in managing symptoms by reducing the frequency and severity of bleeding episodes and possibly the formation of new lesions.

## **Correct Answer Line**
**Correct Answer: C. Sirolimus.**